Katherine Copeland, Ph.D.

Postdoctoral Staff

I study the underlying causes and mechanisms of progressive kidney function decline in relation to diabetes.

My research revolves around progressive kidney function decline (PKFD) in relation to diabetes and its underlying causes and mechanisms. Using transgenic mouse models with miRNA sponges, we aim to identify causality and the relationships between circulating miRNAs, axon guidance pathway proteins, and diabetic kidney disease. My background in targeted and localized drug delivery utilizing nanotechnology urges me to continue this study with the eventual intent of developing a therapeutic to treat PKFD as early as possible. In addition, I am studying cellular senescence of the pre-term placenta in mouse models as part of the Cellular Senescence Network (SenNet). Former Training: B.S. in Microbiology from Mississippi State University (’15); Ph.D. is Biomedical Engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center (’20).

Katherine Copeland on Orcid